NCT03899155
Recruiting
April 2, 2019
May 13, 2022
Brief summary:
Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.
N/A
Arm | Intervention/treatment |
---|---|
Experimental: Nivolumab Dose 1 Specified Dose on Specified Days |
Drug: Nivolumab Solution for IV Injection |
Experimental: Nivolumab Dose 2 Specified Dose on Specified Days |
Drug: Nivolumab Solution for IV Injection |
Inclusion Criteria: - Signed Written Informed Consent Participants who have completed treatment with nivolumab, progressed on prior nivolumab treatment or discontinued nivolumab due to toxicity in the Parent Study are not eligible to receive nivolumab in this study. These participants may be enrolled for safety and survival follow-up only. Participant is eligible for nivolumab treatment as per the Parent Study, and/or Investigator assessed clinical benefit, or Participant is in or has completed the follow-up phase of the Parent Study i) Participant has completed or discontinued treatment, or ii) Participant has progressed on treatment, and/or iii) Participant is on subsequent therapy Exclusion Criteria: - Participant is not eligible for nivolumab treatment as per the Parent Study Participants not receiving clinical benefit as assessed by the Investigator (participant is still eligible for study if entering survival follow-up only) Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant Participants in survival follow-up have no exclusion criteria.
Contact: Recruiting sites have contact information. Please contact the sites directly. If there is no contact information available, please email Clinical.Trials@bms.com
Contact: First line of the email MUST contain NCT# and Site#
United States, California
Local Institution
San Francisco
United States, California
UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Melanoma Center
San Francisco
United States, Colorado
University of Colorado
Aurora
United States, Connecticut
Local Institution
New Haven
United States, District of Columbia
Georgetown-Lombardi Comprehensive Cancer Center
Washington
United States, Florida
Local Institution
Orlando
United States, Florida
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa
United States, Georgia
Local Institution
Atlanta
United States, Illinois
The University of Chicago Medical Center
Chicago
United States, Illinois
Local Institution
Maywood
United States, Kansas
University of Kansas Cancer Center
Westwood
United States, Kansas
Cancer Center of Kansas
Wichita
United States, Kentucky
University of Louisville-James Graham Brown Cancer Center
Louisville
United States, Maryland
Johns Hopkins
Baltimore
United States, Massachusetts
Local Institution
Boston
United States, Massachusetts
Dana_Farber Cancer Institute (DFCI)
Boston
United States, Massachusetts
Local Institution
Boston
United States, Michigan
Local Institution
Ann Arbor
United States, Minnesota
Allina Health
Minneapolis
United States, Missouri
Local Institution
Saint Louis
United States, Nebraska
GU Research Network/Urology Cancer Center
Omaha
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon
United States, New Mexico
Local Institution
Albuquerque
United States, New York
Roswell Park Cancer Institute
Buffalo
United States, New York
Local Institution
New York
United States, New York
Local Institution
New York
United States, New York
Local Institution
New York
United States, New York
Local Institution
New York
United States, North Carolina
Levine Cancer Center
Charlotte
United States, North Carolina
Duke University
Durham
United States, Ohio
Oncology Hematology Care
Cincinnati
United States, Ohio
Local Institution
Cleveland
United States, Ohio
The Ohio University
Columbus
United States, Pennsylvania
Lehigh Valley Hospital
Allentown
United States, Pennsylvania
St. Lukes University Health Network
Easton
United States, Pennsylvania
Local Institution
Philadelphia
United States, Pennsylvania
Local Institution
Philadelphia
United States, Pennsylvania
Hillman Cancer Center- U of Pitts Cancer Institute
Pittsburgh
United States, South Carolina
Charleston Oncology
Charleston
United States, South Carolina
Local Institution
Greenville
United States, Tennessee
Local Institution
Chattanooga
United States, Tennessee
Tennessee Oncology - Nashville
Nashville
United States, Texas
Local Institution
Dallas
United States, Utah
Local Institution
Salt Lake City
United States, Virginia
Local Institution
Charlottesville
United States, Wisconsin
Local Institution
Madison
United States, Wisconsin
UW Health - UW Carbone Cancer Center - Medical Oncology Clinic
Madison
Argentina, Buenos Aires
Centro Oncologico y de Investigacion Buenos Aires
Berazategui
Argentina, Buenos Aires
Instituto Fleming
Caba
Argentina, Tucuman
CAIPO Centro para la Atencion Integraldel Paciente Oncologico
San Miguel De Tucuman
Argentina
Local Institution
Buenos Aires
Argentina
Local Institution
Caba
Argentina
Local Institution
Cordoba
Australia, New South Wales
Local Institution - 0045
Coffs Harbour
Australia, New South Wales
Local Institution - 0062
North Sydney
Australia, New South Wales
Chris OBrien Lifehouse Hospital
Sydney
Australia, New South Wales
Westmead Hospital
Westmead
Australia, Queensland
Local Institution
Greenslopes
Australia, Queensland
Local Institution
South Brisbane
Australia, South Australia
Local Institution
Adelaide
Australia, South Australia
Lyell McEwin Hospital
Elizabeth Vale
Australia, Tasmania
Calvary Mater Newcastle
Waratah
Australia, Victoria
Cabrini Hospital Malvern
Malvern
Austria
Local Institution
Graz
Austria
Local Institution - 0149
Linz
Austria
Allgemeine Krankenhaus Wien
Vienna
Austria
Klinikum Wels- Grieskirchen
Wels
Belgium
Universitair Ziekenhuis Gent
Gent
Belgium
UZ Brussel Campus Jette
Jette
Belgium
Local Institution
Liege
Belgium
Cliniques Universitaires UCL de Mont-Godinne (CHU)
Yvoir
Brazil, RIO Grande DO SUL
ONCOSITE - Centro de Pesquisa Clinica em Oncologia
Ijui
Brazil, RIO Grande DO SUL
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre
Brazil, SAO Paulo
Local Institution
Barretos
Brazil, SAO Paulo
Local Institution
Porto Alegre
Brazil, SAO Paulo
Local Institution - 0262
Sao Jose do Rio Preto
Brazil
Local Institution
Rio de Janeiro
Canada, Alberta
Cross Cancer Institute
Edmonton
Canada, British Columbia
Local Institution
Vancouver
Canada, Nova Scotia
Local Institution
Halifax
Canada, Ontario
Local Institution - 0168
Oshawa
Canada, Quebec
Local Institution
Montreal
Chile, Metropolitana
Fundacion Arturo Lopez Perez
Santiago
Chile, Metropolitana
Local Institution
Santiago
Chile, Metropolitana
Local Institution - 0101
Santiago
Chile, Valparaiso
Local Institution
VinadelMar
China, Anhui
Local Institution
Hefei
China, Beijing
Local Institution
Beijing
China, Guangdong
Local Institution
Guangzhou
China, Heilongjiang
Local Institution
Harbin City
China, Hunan
Local Institution
Changsha
China, Jilin
Local Institution
Changchun City
China, Shanghai
Local Institution
Shanghai
China, Shanghai
Local Institution
Shanghai
Czechia
Local Institution - 0243
Hradec Kralove
Czechia
Local Institution
Olomouc
Denmark
Local Institution
Odense C
Finland
Local Institution
Helsinki
France
Centre Hospitalier Universitaire de Bordeaux Hospital Saint Andre
Bordeaux
France
Centre Hospitalier Intercommunal de Creteil CHIC
Creteil
France
Local Institution - 0074
Dijon Cedex
France
Centre Georges-Francois Leclerc
Dijon Cedex
France
Local Institution - 0010
La Tronche
France
Pole Biologie Pathologie Genetique - CHU de Lille
Lille Cedex
France
APHM - Hopital Nord
Marseille Cedex 20
France
APHM - Hopital de la Timone
Marseille
France
CHU Montpellier
Montpellier
France
Local Institution
Montpellier
France
Hopital europeen Georges Pompidou HEGP
Paris Cedex 15
France
Local Institution - 0028
Paris
France
Local Institution - 0084
Pierre Benite Cedax
France
Local Institution
Rennes
France
Local Institution - 0156
Toulon
France
Local Institution
Toulouse Cedex
France
Local Institution - 0029
Villejuif
Germany, Niedersachsen
Local Institution - 0249
Buxtehude
Germany
Universitaetsklinikum Aachen
Aachen
Germany
Local Institution
Berlin
Germany
Local Institution - 0250
Essen
Germany
Local Institution
Gera
Germany
SRH Wald-Klinikum Gera GmbH
Gera
Germany
Local Institution
Goettingen
Germany
Universitatsmedizin Gottingen
Gottingen
Germany
Local Institution - 0241
Hamburg
Germany
Local Institution
Heidelberg
Germany
Local Institution - 0148
Heidelberg
Germany
Local Institution
Heilbronn
Germany
Local Institution - 0216
Jena
Germany
Local Institution
Kiel
Germany
Unv Schleswig-Holstein Campus Kiel
Kiel
Germany
Local Institution
Koeln
Germany
Katholisches Klinikum Mainz
Mainz
Germany
Local Institution
Mainz
Germany
Local Institution
Munchen
Germany
Local Institution - 0277
Tuebingen
Germany
Universitaetsklinikum Tuebingen
Tuebingen
Greece
Local Institution
Athens
Greece
Sotiria General Hospital of Chest Diseases
Athens
Greece
General Hospital of Athens Alexandra
Athens
Greece
Local Institution
Patras
Greece
Metropolitan Hospital
Piraeus
Greece
Local Institution - 0215
Thessaloniki
Hungary
Local Institution
Budapest
Hungary
Orszagos Koranyi TBC es Pulmonologiai Intezet
Budapest
Hungary
DE Klinikai Kozpont
Debrecen
Ireland
Local Institution
Dublin
Ireland
Local Institution
Limerick
Israel
Local Institution - 0190
Haifa
Israel
Local Institution
Jerusalem
Israel
Local Institution
Petach Tikva
Israel
Local Institution - 0052
Tel Hashomer
Italy, RM
Local Institution - 0033
Roma
Italy
Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari
Bari
Italy
Local Institution
Bergamo
Italy
Local Institution
Genova
Italy
Local Institution
Meldola
Italy
Local Institution
Milano
Italy
IRCCS Istituto Europeo di Oncologia
Milano
Italy
Local Institution - 0267
Milano
Italy
Local Institution
Milano
Italy
Local Institution - 0096
Milan
Italy
Istituto Nazionale dei Tumori
Napoli
Italy
Istituto Nazionale Tumori - Fondazione Pascale Italy
Napoli
Italy
Istituto Oncologico Veneto
Padova
Italy
Local Institution - 0180
Ravenna
Italy
Local Institution - 0003
Siena
Japan, Aichi
Aichi Cancer Center Hospital
Nagoya
Japan, Aomori
Hirosaki University Hospital
Hirosaki
Japan, Hyogo
Kobe City Medical Center General Hospital
Kobe shi
Japan, Ibaraki
University of Tsukuba Hospital
Tsukuba
Japan, Ishikawa
Local Institution
Kanazawa-shi
Japan, Miyagi
Local Institution - 0222
Natori-shi
Japan, Niigata
Niigata Cancer Center Hospital
Chuo-ku Niigata-shi
Japan, Niigata
Niigata University Medical and Dental Hospital
Niigata-Shi
Japan, Osaka
Kindai University Hospital
Osakasayama
Japan, Osaka
Osaka Medical and Pharmaceutical University Hospital
Takatsuki shi
Japan, Tokyo
National Cancer Central Hospital
Chuo-ku
Japan, Tokyo
The Cancer Institute Hospital of JFCR
Koto-Ku
Japan, Tokyo
Keio University Hospital
Shinjuku
Japan
Local Institution - 0224
Fukuoka
Korea, Republic of
Local Institution
Seongnam-si
Korea, Republic of
Local Institution - 0206
Seoul
Korea, Republic of
Local Institution
Suwon Si
Mexico, Ciudad De Mexico
Local Institution - 0181
Tlalpan
Mexico, Guanajuato
Local Institution
Leon
Mexico, Michoacan
Hospital Victoria Medical Center
Morelia
Netherlands
Local Institution
Rotterdam
New Zealand
Local Institution - 0268
Dunedin
Norway
Haukeland Universitetssjukehus
Bergen
Norway
Radiumhospitalet
Oslo
Peru, Lima
Centro de Investigacion Clinica Montesur
Santiago de Surco
Poland
Local Institution - 0120
Gdansk
Poland
Wojewodzkie Centrum Onkologii
Gdansk
Poland
Local Institution - 0031
Lodz
Poland
Ms Pneumed Janusz Milanowski Katarzyna Szmygin-Milanowska Sp. J.
Lublin
Poland
Centrum Medyczne Pratia Poznan
Poznan
Poland
Local Institution
Warsaw
Poland
Wojskowy Instytut Medyczny
Warsaw
Poland
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
Warszawa
Portugal
Centro Hospitalar de Lisboa Norte EPE - HPV
Lisboa
Portugal
Instituto Portugues de Oncologio de Lisboa
Lisbon
Portugal
Local Institution
Porto
Romania, Dolj
Local Institution - 0265
Craiova
Romania
Local Institution - 0129
Bucharest
Romania
Institutul Oncologic Prof. Dr. I. Chiricuta
Cluj Napoca
Romania
Local Institution
Cluj Napoca
Romania
Cardiomed SRL
Cluj-Napoca
Romania
Local Institution - 0133
Oradea
Russian Federation
N.N. Blokhin National Medical Research Center of Oncology
Moscow
Russian Federation
VitaMed LLC
Moscow
Spain, Guipuzcoa
Local Institution - 0047
San Sebastian
Spain
Local Institution - 0122
A Coruna
Spain
Local Institution - 0173
Alicante
Spain
Local Institution - 0123
Badalona
Spain
Hospital Universitari Vall d Hebron
Barcelona
Spain
Local Institution - 0026
Barcelona
Spain
Local Institution - 0225
Barcelona
Spain
Local Institution
Barcelona
Spain
Hospital Universitario de Burgos
Burgos
Spain
Local Institution
Granada
Spain
Centro Oncologico MD ANDERSON Internacional Espana
Madrid
Spain
Local Institution
Madrid
Spain
Hospital Ramon y Cajal
Madrid
Spain
Hospital Universitario Fundacion Jimenez Diaz
Madrid
Spain
Local Institution - 0116
Madrid
Spain
Local Institution
Madrid
Spain
Hospital Universitario HM Sanchinarro
Madrid
Spain
Hospital Regional Universitario Carlos Haya
Malaga
Spain
Local Institution
Santa Cruz de Tenerife
Spain
Local Institution - 0274
Sevilla
Spain
Fundacio Investigao Hospital General Universitario de Valencia FiHgU
Valencia
Spain
Local Institution - 0117
Valencia
Sweden
Local Institution
Goteborg
Sweden
Local Institution
Malmoe
Sweden
Local Institution
Umea
Switzerland
Universitaetsspital Basel - Klinik fuer Onkologie
Basel
Switzerland
UniversitaetsSpital Zuerich - Dermatology
Zurich
Taiwan
Local Institution
Tainan
United Kingdom, Greater London
Local Institution - 0141
London
United Kingdom, Greater London
Local Institution - 0272
London
United Kingdom, Hampshire
Southampton General Hospital
Southampton
United Kingdom, Kent
Local Institution
Maidstone
United Kingdom, Middlesex
Local Institution - 0161
Northwood
United Kingdom
Local Institution - 0086
London
United Kingdom
The Christie Hospital
Manchester
Bristol-Myers Squibb
Study Director: Bristol-Myers Squibb Bristol-Myers Squibb